secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lakeside Holding Ltd (LSH)
CIK:        0001996192
Form:       8-K
Filed at:   2025-05-15T23:59:59+00:00
Accession:  0001213900-25-044243
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lakeside Q3 FY2025 revenue falls 15% to $3.8M; net loss of $1.07M vs prior profit
--------------------------------------------------------------------------------

- Total revenue $3.80M, down from $4.46M YoY; cross-border freight fell 26%, pharma distribution added $0.50M.
- Net loss attributable to Lakeside $1.07M ($0.14 per share) vs net income $0.01M in Q3 FY2024.
- Nine-month net loss $4.35M ($0.58 per share) vs $0.23M loss a year ago; operating expenses rose to $5.60M from $2.90M.
- Hupan Pharma acquisition closed Nov 2024; contributed $715K to nine-month revenue. Convertible debt up to $4.5M secured March 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1996192/000121390025044243/0001213900-25-044243-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1996192/000121390025044243/ea0242416-8k_lakeside.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-044243

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer